Reuters logo
7 months ago
BRIEF-Sharp Edge Labs enters into drug discovery collaboration with Sumitomo Dainippon Pharma
January 3, 2017 / 5:12 PM / 7 months ago

BRIEF-Sharp Edge Labs enters into drug discovery collaboration with Sumitomo Dainippon Pharma

1 Min Read

Jan 3 (Reuters) - Sharp Edge Labs, Inc:

* Enters into drug discovery collaboration with Sumitomo Dainippon Pharma

* Under collaboration, Sumitomo Dainippon to make its proprietary compound library available to Co for use in drug discovery platform

* Co's proprietary biosensor platform will be used to screen, identify compounds to correct trafficking defects in neurodegenerative diseases Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below